Source - RNS
RNS Number : 1965H
Circassia Pharmaceuticals Plc
05 June 2017
 

For immediate release

 

Circassia Pharmaceuticals plc

 

Persons Discharging Managerial Responsibilities and persons closely associated with them notification

 

Oxford, UK - 5 June 2017: Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) Persons Discharging Managerial Responsibilities and persons closely associated with them notification.

 

This form is for the use of persons discharging managerial responsibilities (PDMRs) as well as persons closely associated with them to notify transactions to the FCA under Article 19(1) of Regulation (EU) No 596/2014 of the European Parliament and of the Council on market abuse ("The Market Abuse Regulation").

 

Once this form has been sent to the designated email address, it constitutes the "secure means of transmission" mandated in Article 2 of Regulation (EU) 2016/523. PDMRs as well as persons closely associated with them are required to use this form when submitting a notification under this article.

 

PDMR Notification Form Page

 

1 - Details of the person discharging managerial responsibilities/person closely associated

 

Name of natural person*

Jean Jacques Garaud

 

 

2 - Reason for the notification

 

Position/status*

Non-Executive Director (PDMR)

Initial notification/amendment*

Initial Notification

In case of amendment, please enter the previous notification reference number and explain the error that this notification needs amending

N/A

 

 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

Full name of entity*

Circassia Pharmaceuticals plc

Legal Entity Identifier code

2138006YAT138TOGA556


In accordance with ISO 1744 LEI code

 

 

4 - Details of the transaction(s)

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

Date

Description of Financial Transaction

Aggregated Price

Aggregated Volume

Total Aggregated Price

02-Jun-17

Exercise of options

£0.0008

77,500

£62.00

02-Jun-17

Sale of shares

£0.8911

77,500

£69,060.25

 

 

i.          Exercise of options

 

Description of the financial instrument, type of instrument*

Circassia Holdings Ltd 2007 Unapproved Option Scheme

Identification Code*

GB00BJVD3B28

Nature of the transaction*

Exercise of options

Currency*

GBP

Price(s) and Volume (s)

Price

Volume

Total

£0.0008p

77,500

£62.00

Aggregated Information

Price

Volume

Total

£0.0008p

77500

£62.00

Date of Transaction*

2 June 2017

Place of Transaction*

London: XLON

 

 

ii.         Sale of shares following exercise of options

 

Description of the financial instrument, type of instrument*

Circassia Holdings Ltd 2007 Unapproved Option Scheme

Identification Code*

GB00BJVD3B28

Nature of the transaction*

Sale of shares

Currency*

GBP

Price(s) and Volume (s)

Price

Volume

Total

£0.8911p

77,500

£69,060.25

Aggregated Information

Price

Volume

Total

£0.8911p

77,500

£69,060.25

Date of Transaction*

2 June 2017

Place of Transaction*

London: XLON

 

-Ends-

 

For further information, please contact:

Circassia Pharmaceuticals plc

Julien Cotta, Company Secretary

 

+44 (0) 1865 405560

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBLGDLUXGBGRU